Uploaded May 2025 | Updated November 2026, 1 day ago
How do you go from one on-demand CRISPR therapy to a world where CRISPR therapies are available to everyone who could benefit? Petros Giannikopoulos explains the engineering problem of building the new medical field of "interventional genomics" and the significance of the recent achievement of designing and delivering a personalized gene-editing therapy in just 6 months.
Learn more: innovativegenomics.org/news/first-patient-treated-with-on-demand-crispr-therapy
How do you go from one on-demand CRISPR therapy to a world where CRISPR therapies are available to everyone who could benefit? Petros Giannikopoulos explains the engineering problem of building the new medical field of "interventional genomics" and the significance of the recent achievement of designing and delivering a personalized gene-editing therapy in just 6 months.
Learn more: innovativegenomics.org/news/first-patient-treated-with-on-demand-crispr-therapy





![Richard Hynes: National Academies of Sciences, Engineering, and Medicine Report
Richard Hynes (MIT) explains recent stances and regulations regarding human genome editing. [2017 CRISPR Workshop] Richard Hynes: National Academies of Sciences, Engineering, and Medicine Report](https://i.ytimg.com/vi/YJPKpTfWuZE/mqdefault.jpg)




